Literature DB >> 2124218

Apathy and indifference in patients on fluvoxamine and fluoxetine.

R Hoehn-Saric1, J R Lipsey, D R McLeod.   

Abstract

Apathy, indifference, loss of initiative, or disinhibition (without concurrent sedation or hypomania) were observed among five patients receiving the serotonin reuptake blocking antidepressants fluvoxamine or fluoxetine. These effects appeared to be dose related. They disappeared rapidly when the dose of fluvoxamine, which has a short half-life, was reduced. Fluoxetine, which has a long half-life, was more difficult to titrate. A possible relationship between mild drug-induced indifference and the therapeutic effects of serotonin reuptake blocking medication in anxiety disorders is discussed.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2124218

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN: 0271-0749            Impact factor:   3.153


  25 in total

Review 1.  Apathy in neurologic disorders.

Authors:  J Duffy
Journal:  Curr Psychiatry Rep       Date:  2000-10       Impact factor: 5.285

2.  Inhibition of endocannabinoid degradation rectifies motivational and dopaminergic deficits in the Q175 mouse model of Huntington's disease.

Authors:  Dan P Covey; Hannah M Dantrassy; Samantha E Yohn; Alberto Castro; P Jeffrey Conn; Yolanda Mateo; Joseph F Cheer
Journal:  Neuropsychopharmacology       Date:  2018-06-01       Impact factor: 7.853

3.  A randomized controlled trial of fluoxetine in the treatment of cocaine dependence among methadone-maintained patients.

Authors:  Erin L Winstanley; George E Bigelow; Kenneth Silverman; Rolley E Johnson; Eric C Strain
Journal:  J Subst Abuse Treat       Date:  2011-01-26

Review 4.  Behavioural toxicity of medicinal drugs. Practical consequences, incidence, management and avoidance.

Authors:  J G Ramaekers
Journal:  Drug Saf       Date:  1998-03       Impact factor: 5.606

Review 5.  Antidepressant effects on emotional temperament: toward a biobehavioral research paradigm for major depressive disorder.

Authors:  David P Soskin; Jenna R Carl; Jonathan Alpert; Maurizio Fava
Journal:  CNS Neurosci Ther       Date:  2012-06       Impact factor: 5.243

Review 6.  Benefit-risk considerations in the treatment of dementia with Lewy bodies.

Authors:  Margaret M Swanberg; Jeffrey L Cummings
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

7.  Neuroanatomical correlates of apathy in late-life depression and antidepressant treatment response.

Authors:  Genevieve S Yuen; Faith M Gunning; Eric Woods; Sibel A Klimstra; Matthew J Hoptman; George S Alexopoulos
Journal:  J Affect Disord       Date:  2014-05-22       Impact factor: 4.839

8.  Aripiprazole for Treatment of Apathy.

Authors:  Varun Monga; Prasad R Padala
Journal:  Innov Clin Neurosci       Date:  2015 Sep-Oct

9.  A placebo-controlled trial of fluoxetine added to neuroleptic in patients with schizophrenia.

Authors:  D C Goff; K K Midha; O Sarid-Segal; J W Hubbard; E Amico
Journal:  Psychopharmacology (Berl)       Date:  1995-02       Impact factor: 4.530

Review 10.  Comparative tolerability profiles of the newer versus older antidepressants.

Authors:  M V Rudorfer; H K Manji; W Z Potter
Journal:  Drug Saf       Date:  1994-01       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.